Sintetica
Switzerland - MendriosiBiotechnology
Focus: Sintetica is a Swiss-based mid-cap biotech (201–500 employees) founded in 1921, specializing in analgesics and anesthetics with emerging ophthalmology programs. The company operates as a clinical-stage developer with a focused pipeline in local anesthetics and pain management.
Profile data last refreshed 23h ago · AI intelligence enriched 3w ago
Employees
201-500
Open Jobs
0
About Sintetica
AI assessmentNot HiringNo open roles listed right now. Follow Sintetica to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
2-chloroprocaine hydrochloride, 1%
Neurological Complication, in Particular TNS or CESClinical Trials (1)
NCT02067806Observational Study on 2-chloroprocaine Hydrochloride 1%
N/AHelp build intelligence for Sintetica
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.